Clinical Trials Directory

Trials / Completed

CompletedNCT03855891

Micro-RNA Profile in Patients With Different Stages of Atherosclerosis According to CTA

Evaluation of the Circulating Micro-RNA Profile Specificity in Patients With Different Stages of Atherosclerosis According to MSCT Coronary Angiography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
I.M. Sechenov First Moscow State Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this single-center study is to determine the spectrum and levels of cardiospecific circulating microRNAs in patients with different stages of atherosclerosis according to 640-slice multispiral computed tomography (MSCT).

Detailed description

The study will be conducted in two phases. Phase one. After signing the informed consent, patients with coronary heart disease, angina pectoris II-IV functional class, who underwent MSCT angiography of the coronary arteries for medical reasons, regulated in the relevant ESC and the Russian Society of Cardiology guidelines, will be included in the study. According to the results of MSCT, the participants will be divided into 4 groups: those with atherosclerotic plaques with signs of instability; those with stable atherosclerotic plaques without marked calcification; those with calcined atherosclerotic plaques; those with no signs of atherosclerosis of the coronary arteries. Plasma samples will be analyzed by microarray, using a cardiospecific set. Phase two. Validation of the results obtained after the first phase will be performed on a larger sample of patients. Patients after signing an informed consent will also undergo MSCT angiography of coronary arteries and according to its results will be devided in 4 groups. To assess the level of microRNA expression in the blood of patients, real-time reverse transcription-polymerase chain reaction (RT-PCR) will be used. The expected result of the study. For the first time ever, there will be determined the profile of circulating regulatory RNA in patients who underwent MSCT angiography of coronary arteries. Features of expression of circulating microRNAs will be compared with different severity degrees of the atherosclerotic process based on MSCT criteria. The results will be compared with each other (including the "control" group), which will allow to identify common patterns and specific differences.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTblood testBlood test for spectrum and level of cardiospecific micro-RNA

Timeline

Start date
2019-01-01
Primary completion
2020-08-14
Completion
2020-10-01
First posted
2019-02-27
Last updated
2020-12-22

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03855891. Inclusion in this directory is not an endorsement.